The diverse habitats of obligate intracellular parasites

Current Opinion in Microbiology

Volumn 1, Issue 1, 1998, Pages 82-87

  Hackstadt, Ted ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

CELL VACUOLE; CHLAMYDIA; CHLAMYDIASIS; COXIELLA; EHRLICHIA; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RICKETTSIA; RICKETTSIACEAE; RICKETTSIOSIS;

CHLAMYDIA; CHLAMYDIA INFECTIONS; COXIELLA; EHRLICHIA; HUMANS; RICKETTSIA; RICKETTSIACEAE; RICKETTSIACEAE INFECTIONS; VACUOLES;

EID: 0031987892     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80146-X     Document Type: Article

References (60)

1. Tam JE, Davis CH, Wyrick PB: Expression of recombinant DNA introduced into Chlamydia trachomatis by electroporation. Can J Microbiol 1994, 40:583-591.
2. Suhan ML, Chen SY, Thompson HA: Transformation of Coxiella burnetii to ampicillin resistance. J Bacteriol 1996, 178:2701-2708. This is the first indication of stable genetic transformation of Coxiella burnetii.
3. Finlay BB, Cossart P: Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997, 276:718-725.
4. Garcia-del Portillo F, Finlay BB: The varied lifestyles of intracellular pathogens within eukaryotic vacuolar compartments. Trends Microbiol 1995, 3:373-380.
5. Clemens DL: Characterization of the Mycobacterium tuberculosis phagosome. Trends Microbiol 1996, 4:113-118.
6. Russell DG: Mycobacterium and Leishmania: stowaways in the endosomal network. Trends Cell Biol 1996, 5:125-128.
7. Moulder JW: Comparative biology of intracellular parasitism. Microbiol Rev 1985, 49:298-337.
8. Hackstadt T: The biology of Rickettsiae. Infect Agents Dis 1996, 5:127-143.
9. Winkler HH, Miller ET: Phospholipase A activity in the hemolysis of sheep and human erythrocytes by Rickettsia prowazeki. Infect Immun 1980, 29:316-321.
10. Winkler HH, Miller ET: Phospholipase A and the interaction of Rickettsia prowazekii and mouse fibroblast L-929 cells. Infect Immun 1982, 38:109-113.
11. Ramm LE, Winkler HH: Rickettsial hemolysis: effect of metabolic inhibitors upon hemolysis and adsorption. Infect Immun 1973, 7:550-555.
12. Ramm LE, Winkler HH: Rickettsial hemolysis: adsorption of rickettsiae to erythrocytes. Infect Immun 1973, 7:93-99.
13. Winkler HH, Daughterly RM: Phospholipase A activity associated with the growth of Rickettsia prowazekii in L929 cells. Infect Immun 1989, 57:36-40.
14. Winkler HH, Day L, Daugherty R: Analysis of hydrolytic products from choline-labeled host cell phospholipids during growth of Rickettsia prowazekii. Infect Immun 1994, 62:1457-1459.
15. Marquis H, Goldfine H, Portnoy DA: Proteolytic pathways of activation and degradation of a bacterial phospholipase C during intracellular infection by Listeria monocytogenes. J Cell Biol 1997, 137:1381-1392.
16. Walker DH, Tidwell RR, Rector TM, Geratz JD: Effect of synthetic protease inhibitors of the amidine type on cell injury by Rickettsia rickettsii. Antimicrob Agents Chemother 1984, 25:582- 585.
17. Silverman DJ, Santucci LA, Meyers N, Sekeyova Z: Penetration of host cells by Rickettsia rickettsii appears to be mediated by a phospholipase of rickettsial origin. Infect Immun 1992, 60:2733-2740.
18. Heinzen RA, Hayes SF, Peacock MG, Hackstadt T: Directional actin polymerization associated with spotted fever group rickettsia infection of vero cells. Infect Immun 1993, 61:1926-1935.
19. Walker DH, Dumler JS: Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 1996, 2:19-29.
20. Rikihisa Y: The tribe ehrlichieae and ehrlichial diseases. Clin Microbiol Rev 1991, 4:286-308.
21. Wells MY, Rikihisa Y: Lack of lysosomal fusion with phagosomes containing Ehrlichia risticii in P388D1 cells: abrogation of inhibition with oxytetracycline. Infect Immun 1988, 56:3209-3215.
22. Barnewall RE, Rikihisa Y, Lee EH: Ehrlichia chaffeensis inclusions are early endosomes which selectively accumulate transferrin receptor. Infect Immun 1997, 65:1455-1461. Defines the characteristics of the Ehrlichia chaffeensis parasitophorous vacuole to indicate that it displays properties of an early endosome arrested in development. The properties appear at least superficially similar to those of mycobacteria-containing vesicles.
23. Sturgill-Koszycki S, Schaible UE, Russell DG: Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J 1996, 15:6960-6968.
24. Russell DG, Dant J, Sturgill-Koszycki S: Mycobacterium avium-and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J Immunol 1996, 156:4764-4773,
25. Reimer LG: Q fever. Clin Microbiol Rev 1993, 6:193-198.
26. McCaul TF, Williams JC: Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 1981, 147:1063-1076.
27. McCaul TF, Hackstadt T, Williams JC. Ultrastructural and biological aspects of Coxiella burnetii under physical disruptions. In: Rickettsiae and Rickettsial Diseases. Edited by Burgdorfer W, Anacker RL. New York: Academic Press, Inc; 1981:267-279.
28. Hackstadt T, Williams JC: Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci USA 1981, 78:3240-3244.
29. Hackstadt T, Williams JC: Stability of the adenosine 5′-triphosphate pool in Coxiella burnetii: influence of pH and substrate. J Bacteriol 1981, 148:419-425.
30. Hackstadt T: Estimation of the cytoplasmic pH of Coxiella burnetii and effect of substrate oxidation on proton motive force. J Bacteriol 1983, 154:591-597.
31. Heinzen RA, Scidmore MA, Rockey DD, Hackstadt T: Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis, Infect Immun 1996, 64:796-809. Compares and contrasts the properties of the different vacuoles occupied by Coxiella burnetii and Chlamydia trachomatis.
32. Akporiaye ET, Rowatt JD, Aragon AA, Baca OG: Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii. Infect Immun 1983, 40:1155-1162.
33. Baca OG, Li YP, Kumar H: Survival of the Q fever agent Coxiella burnetii in the phagolysosome. Trends Microbiol 1994, 2:476-480.
34. Rabinovitch M, Veras PST: Cohabitation of Leishmania amazonensis and Coxiella burnetii. Trends Microbiol 1996, 4:158-161. Good review of the fusogenicity of Coxiella burnetii vacuoles with other parasitophorous vacuoles.
35. Moulder JW: Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991, 55:143-190.
36. Friis RR: Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development. J Bacteriol 1972, 110:706-721.
37. Lawn AM, Blyth WA, Taverne J: Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy. J Hyg 1973, 71:515-532.
38. Wyrick PB, Brownridge EA: Growth of Chlamydia psittaci in macrophages. Infect Immun 1978, 19:1054-1060.
39. Scidmore MA, Fischer ER, Hackstadt T: Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol 1996, 134:363-374. This study shows that the interruption of sphingomyelin export by the chamydial inclusion is not accompanied by a general inhibition of glycoprotein maturation or export. The implication is that a subset of exocytic vesicles, with an unknown cargo, is fusogenic with the inclusion.
40. Taraska T, Ward DM, Ajioka RS, Wyrick PB, Davis-Kaplan SR, Davis CH, Kaplan J: The late Chlamydial inclusion membrane is not derived from the endocytic pathway and is relatively deficient in host proteins. Infect Immun 1996, 64:3713-3727. Together with Heinzen et al. 1996 [31••] and Scidmore et al. 1996 [39•• ], this paper demonstrates that the chlamydial inclusion does not fuse with endocytic compartments.
41. Hackstadt T, Scidmore MA, Rockey DD: Lipid metabolism in Chlamydia trachomatis infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci USA 1995, 92:4877-4881.
42. 6-NBD-sphingomyelin to the chlamydial inclusion.
43. Lipsky NG, Pagano RE: A vital stain for the Golgi apparatus. Science 1985, 228:745-747.
44. Pagano RE, Sepanski MA, Martin OC: Molecular trapping of a fluorescent ceramide analogue at the golgi apparatus of fixed cells: interaction with endogenous lipids provides a trans-Golgi marker for both light and electron microscopy. J Cell Biol 1989, 109:2067-2079.
45. Rosenwald AG, Pagano RE: Intracellular transport of ceramide and its metabolites at the Golgi complex: insights from shortchain analogs. In Advances in Lipid Research, vol. 26: Academic Press, Inc, 1993:101-118.
46. Hacksladt T, Fischer ER, Scidmore MA, Rockey DD, Heinzen RA: Origins and functions of the chlamydial inclusion. Trends Microbiol 1997, 5:288-293.
47. Lipsky NG, Pagano RE: Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the Golgi apparatus en route to the plasma membrane. J Cell Biol 1985, 100:27-34.
48. Van Meer G, Stelzer EHK, Winjnaendts-van-Resandt RW, Simons K: Sorting of sphingolipids in epithelial (Madin-Darby Canine Kidney) cells. J Cell Biol 1987, 105:1623-1635.
49. Koval M, Pagano RE: Intracellular transport and metabolism of sphingomyelin. Biochim Biophys Acta 1991, 1082:113-125.
50. Scidmore MA, Rockey DD, Fischer ER, Heinzen RA, Hackstadt T: Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect Immun 1996, 64:5366-5372. This manuscript demonstrates that modification of the nascent chlamydial inclusion so that it intersects an exocytic pathway is dependent upon chlamydial polypeptide synthesis rather than on route of entry. This means of defining the properties of the parasitophorous vacuole contrasts with the paradigm of Toxoplasma gondii, in which the route of infection determines the properties of the vacuole.
51. Joiner KA, Fuhrman SA, Miettinen HM, Kasper LH, Mellman I: Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science 1990, 249:641-646.
52. Ojcius DM, Hellio R, Dautry-Varsat A: Distribution of endosomal, lysosomal, and major histocompatability complex markers in a monocytic cell line infected with Chlamydia psittaci. Infect Immun 1997, 65:2437-2442.
53. Eissenberg LG, Wyrick PB, Davis CH, Rumpp JW: Chlamydia psittaci elementary body envelopes: ingestion and inhibition of phagolysosome fusion. Infect Immun 1983, 40:741-751.
54. Van Ooij C, Apodaca G, Engel J: Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun 1997, 65:758-766.
55. Schramm N, Bagnell CR, Wyrick PB: Vesicles containing Chlamydia trachomatis serovar L2 remain above pH 6 within HEC-1B cells. Infect Immun 1996, 64:1208-1214. Describes the first actual measurement of pH within inclusions.
56. Schwab JC, Beckers CJM, Joiner KA: The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc Natl Acad Sci USA 1994, 91:509-513.
57. Heinzen RA, Hackstadt T: The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low molecular weight compounds. Infect Immun 1997, 65:1088-1094.
58. Rockey DD, Heinzen RA, Hackstadt T: Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized to the inclusion membrane of infected cells. Mol Microbiol 1995, 15:617-626.
59. Via LE, Deretic D, Ulmer RJ, Hibler NS, Huber LA, Deretic V: Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J Biol Chem 1997, 272:13326-13331.
60. Moulder JW: Intracellular parasitism: life in an extreme environment, J Infect Dis 1974, 130:300-306.